Expert Consensus on the Use of Traditional Chinese Patent Medicines in the Prevention and Treatment of Pan-vascular Diseases and Their Target Organ Damage

Pan-vascular diseases, one of the leading causes of death among Chinese residents, represent a systemic vascular syndrome characterized by atherosclerosis as a common pathological feature. This condition can lead to damage in multiple target organs, including the heart, brain, kidneys, retina, and peripheral vessels. Current prevention and control efforts face critical challenges. Western medicine's disciplinary specialization often leads to excessive focus on localized lesions, whereas Traditional Chinese Medicine's (TCM) holistic diagnostic and therapeutic system offers distinct advantages in systemic management. Evidence-based research confirms the efficacy of Chinese patent medicines in treating systemic vascular diseases, particularly those related to atherosclerosis. Currently, there is a lack of clinical guidelines based on evidence-based medicine for the prevention and treatment of pan-vascular diseases and their target organ damage using Chinese patent medicines, both domestically and internationally. This consensus was initiated by the China association for the Promotion of Traditional Chinese Medicine. Under the academic guidance of Academician GE Junbo and Academician CHEN Kejie, Experimental research center, China Academy of Chinese Medical Sciences led the formation of the Expert Group for the "Expert Consensus on the Use of Traditional Chinese Patent Medicines in the Prevention and Treatment of Pan-vascular Diseases and Their Target Organ Damage". This consensus was developed through a panel of renowned physicians, covering consensus development methodologies, TCM theoretical interpretations of pan-vascular diseases, evidence-based recommendations for TCM patent medicines in their prevention and treatment, and clinical application considerations. It aims to provide an optimized integrated Chinese and Western medicine solution for the comprehensive management of pan-vascular diseases, standardize the principles of TCM patent medicine use in preventing and treating pan-vascular diseases and target organ damage, and enhance the scientific rigor and standardization of clinical practice.